BMJ  2008;336:737 (5 April), doi:10.1136/bmj.39539.578507.DB

News

Trial participants need to be more representative of patients

Bob Roehr

1 Washington, DC

The first 150 words of the full text of this article appear below.

A new report is calling for changes in the conduct of clinical trials in the United States to reduce disparities of age, sex, race, and comorbidity. The goal is to give a more representative picture of the benefits and risks of a treatment across the entire population but particularly among those who bear the greatest burden of the morbidity.

The eliminating disparities in clinical trials (EDICT) initiative was conducted over two years by the Baylor College of Medicine in Houston and the Intercultural Cancer Council. It is part of an ongoing four year project to reduce barriers to participation in trials. The report of the initiative was released on 1 April in Washington, DC.

The report describes itself as a "nationwide call to action . . . that removes the barriers to clinical trial participation and advances education and information sharing [as] a critical step to improving the health status . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Patients and the public deserve big changes in evaluation of drugs
Silvio Garattini and Iain Chalmers
BMJ 2009 338: b1025. [Extract] [Full Text]

This article has been cited by other articles:

  • Garattini, S., Chalmers, I. (2009). Patients and the public deserve big changes in evaluation of drugs. BMJ 338: b1025-b1025 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ